Abstract
The Baeyer-Villiger oxidation of ketones represents a powerful methodology in synthesis to break carbon-carbon bonds in an oxygen insertion process. Since the discovery of the reaction by Adolf Baeyer and Victor Villiger in 1899 substantial progress has been made to understand the mechanism, to predict migratory preference, and to apply this conversion in preparative chemistry. Chiral Baeyer-Villiger oxidation of cyclic ketones allows rapid access to asymmetric lactones as valuable intermediates in organic chemistry and frequently encountered precursors in enantioselective synthesis. In recent years, organometal catalysts and other artificial catalytic entities have been continuously improved and represent promising approaches for future process developments. Complementing this strategy, biocatalysis offers a “green chemistry” alternative for this transformation. This review will give a comprehensive summary of strategies to perform Baeyer-Villiger reactions in an enantioselective manner. A discussion of scope and limitations of both organometallic approaches and biocatalytic methods includes substrate profiles, improvement of optical purity, and implications upon scale-up.
Keywords: enantioselective baeyer-villiger oxidations, chiral baeyer-villiger oxidation, cyclic ketones, enantioselective synthesis
Current Organic Chemistry
Title: Enantioselective Baeyer-Villiger Oxidations
Volume: 8 Issue: 12
Author(s): Marko D. Mihovilovic, Florian Rudroff and Birgit Grotzl
Affiliation:
Keywords: enantioselective baeyer-villiger oxidations, chiral baeyer-villiger oxidation, cyclic ketones, enantioselective synthesis
Abstract: The Baeyer-Villiger oxidation of ketones represents a powerful methodology in synthesis to break carbon-carbon bonds in an oxygen insertion process. Since the discovery of the reaction by Adolf Baeyer and Victor Villiger in 1899 substantial progress has been made to understand the mechanism, to predict migratory preference, and to apply this conversion in preparative chemistry. Chiral Baeyer-Villiger oxidation of cyclic ketones allows rapid access to asymmetric lactones as valuable intermediates in organic chemistry and frequently encountered precursors in enantioselective synthesis. In recent years, organometal catalysts and other artificial catalytic entities have been continuously improved and represent promising approaches for future process developments. Complementing this strategy, biocatalysis offers a “green chemistry” alternative for this transformation. This review will give a comprehensive summary of strategies to perform Baeyer-Villiger reactions in an enantioselective manner. A discussion of scope and limitations of both organometallic approaches and biocatalytic methods includes substrate profiles, improvement of optical purity, and implications upon scale-up.
Export Options
About this article
Cite this article as:
Mihovilovic D. Marko, Rudroff Florian and Grotzl Birgit, Enantioselective Baeyer-Villiger Oxidations, Current Organic Chemistry 2004; 8 (12) . https://dx.doi.org/10.2174/1385272043370159
DOI https://dx.doi.org/10.2174/1385272043370159 |
Print ISSN 1385-2728 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5348 |
Call for Papers in Thematic Issues
Catalytic C-H bond activation as a tool for functionalization of heterocycles
The major topic is the functionalization of heterocycles through catalyzed C-H bond activation. The strategies based on C-H activation not only provide straightforward formation of C-C or C-X bonds but, more importantly, allow for the avoidance of pre-functionalization of one or two of the cross-coupling partners. The beneficial impact of ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Drug-Like Inhibitors of Protein-Protein Interactions: A Structural Examination of Effective Protein Mimicry
Current Protein & Peptide Science Neutrophil Elastase as a Target in Lung Cancer
Anti-Cancer Agents in Medicinal Chemistry Editorial [Hot Topic: Targeting Arterial Thrombosis - Current Concepts and Future Developments (Guest Editor: Florian Krotz)]
Current Drug Targets Enhanced Butyrylcholinesterase Activity may be the Common Link in Triggering Low-Grade Systemic Inflammation and Decrease in Cognitive Function in Diabetes Mellitus and Alzheimers disease
Current Nutrition & Food Science Fatty Acids and Effects on In Vitro and In Vivo Models of Liver Steatosis
Current Medicinal Chemistry Static Cerebral Blood Flow Autoregulation in Humans
Current Hypertension Reviews Molecular Basis for Designing Selective Modulators of Retinoic Acid Receptor Transcriptional Activities
Current Drug Targets - Immune, Endocrine & Metabolic Disorders Exploring N<sup>1</sup>-p-Fluorobenzyl-Cymserine as an Inhibitor of 5-Lipoxygenase as a Candidate for Type 2 Diabetes and Neurodegenerative Disorder Treatment
CNS & Neurological Disorders - Drug Targets Plasma Ghrelin Levels in Patients with Familial Mediterranean Fever
Protein & Peptide Letters The Use of Interferons in Respiratory Diseases
Current Respiratory Medicine Reviews A Simple and Rapid Method for Selecting High Producers of Recombinant Proteins in Individual Clones of P. pastoris
Combinatorial Chemistry & High Throughput Screening Cardioprotection Techniques: Preconditioning, Postconditioning and Remote Con-ditioning (Basic Science)
Current Pharmaceutical Design SDR Structure, Mechanism of Action, and Substrate Recognition
Current Organic Chemistry Molecular Targets of FTY720 (Fingolimod)
Current Molecular Medicine Multiple Sclerosis: Current and Future Treatment Options
Endocrine, Metabolic & Immune Disorders - Drug Targets Virtual Screening for the Development of Dual-Inhibitors Targeting Topoisomerase IB and Tyrosyl-DNA Phosphodiesterase 1
Current Drug Targets TTR Fibril Formation Inhibitors: Is there a SAR?
Current Medicinal Chemistry Antagonism of Eosinophil Accumulation in Asthma
Recent Patents on Inflammation & Allergy Drug Discovery Editorial (Hot Topic: Treatment of Atherosclerosis as an Inflammatory Disease)
Current Pharmaceutical Design Cytokine Profile in Patients Infected with Anisakis simplex in Endemic Areas: Dietary Intervention with Polyphenols: A Working Hypothesis
Endocrine, Metabolic & Immune Disorders - Drug Targets